Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Human Polyclonal APOA2 Primary Antibody for WB - ABIN1881065
Knott, Priestley, Urdea, Scott: Isolation and characterisation of a cDNA encoding the precursor for human apolipoprotein AII. in Biochemical and biophysical research communications 1984
Show all 5 references for ABIN1881065
Human Polyclonal APOA2 Primary Antibody for IHC (p) - ABIN1882063
Duesing, Charpentier, Marre, Tichet, Hercberg, Balkau, Froguel, Gibson: Evaluating the association of common APOA2 variants with type 2 diabetes. in BMC medical genetics 2009
Show all 2 references for ABIN1882063
Human Polyclonal APOA2 Primary Antibody for ELISA, WB - ABIN1842294
Fong, Rodrigues, Salter, Yip, Despres, Angel, Gregg: Characterization of high density lipoprotein binding to human adipocyte plasma membranes. in The Journal of clinical investigation 1985
The expression of ApoA-I (show APOA1 Antibodies) and ApoA-II mRNA in the reproductive tract and their antibacterial properties against Escherichia coli suggest that seminal apolipoproteins play an important role in innate immunity in the rainbow trout reproductive tract.
ApoAII-ATQ (show ALDH7A1 Antibodies)/AT not only distinguished the early stages of pancreatic cancer from healthy controls but also identified patients at high risk for pancreatic malignancy.
ApoA1 (show APOA1 Antibodies) and ApoA2 were independently associated with cognitive impairment.
Plasma apoB (show APOB Antibodies) pool size of VLDL containing apoA-II is much smaller than that of VLDL without apoA-II, and this was caused by a very low rate of secretion of this VLDL type into plasma.
Clematichinenoside prevented dyslipidemia-induced atherosclerosis via hepatic PPARalpha (show PPARA Antibodies)/APOA1 (show APOA1 Antibodies)/APOA2/APOC3 (show APOC3 Antibodies) metabolism.
APOA-II polymorphism and oxidative stress is associated with poor prognosis in patients with type 2 diabetes.
Apolipoprotein AII was detected as a protein associated with the urinary protein/urinary creatinine levels in pediatric idiopathic steroid-sensitive nephrotic syndrome
Apolipoprotein A-II/B significantly improves risk prediction of overall survival, also in carotid surgery patients with lower LDL levels
Apolipoprotein A-II and the regulation of high density lipoproteins in cardiovascular disease. [Review]
influence of apolipoprotein A-I (show APOA1 Antibodies) and apolipoprotein A-II availability on nascent HDL (show HSD11B1 Antibodies) heterogeneity
We have cloned the cDNA encoding human ApoA-II and achieved its high-level secreting expression with a yield of 65 mg/L of yeast culture
In vivo, neither C57 nor FVB apoA-II protein levels are affected by the absence of apoE (show APOE Antibodies), while an apoE (show APOE Antibodies)/apoA-I (show APOA1 Antibodies) double deficiency results in a 50% decrease of plasma FVB apoA-II but results in undetectable levels of C57 apoA-II in the plasma.
ApoA-I (show APOA1 Antibodies) deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.
Exacerbated hepatitis is observed in ApoA-II-deficient mice, indicating that ApoA-II plays a suppressive role in concanavalin A-induced hepatitis under physiological conditions.
Apoa2 injected into mice induced amyloidosis.
the presence of apoA-II on HDL (show HSD11B1 Antibodies) particles inhibits the ability of endothelial lipase (show LIPG Antibodies) to influence the metabolism of HDL (show HSD11B1 Antibodies) in vivo
These studies indicate that increased levels of APOA2 protein lead to earlier and greater amyloid deposition and enhanced sensitivity to the transmission of amyloid fibrils in transgenic mice.
ApoAII is efficiently reabsorbed in kidney proximal tubules in relation to its plasma concentration
apoAII regulates the metabolism of triglyceride-rich lipoproteins, with HDL (show HSD11B1 Antibodies) serving as a plasma reservoir of apoAII that is transferred to the triglyceride-rich lipoproteins in the same way as VLDL and chylomicrons acquire most of their apoCs from HDL (show HSD11B1 Antibodies)
To understand the mechanism of amyloid fibril formation by apoA-II, we examined the polymerization of synthetic partial peptides of apoA-II in vitro.
The bovine APOA2 gene may be a strong candidate gene for body traits in the cattle breeding program.
The APOA2:c.131T>A polymorphism was associated with the fatty acid composition of backfat.
This gene encodes apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia.
, apolipoprotein A2
, antimicrobial peptide BAMP-1